Compare · RCM vs TPVG
RCM vs TPVG
Side-by-side comparison of R1 RCM Inc. (RCM) and TriplePoint Venture Growth BDC Corp. (TPVG): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both RCM and TPVG operate in Other Consumer Services (Consumer Discretionary), so they compete in similar markets.
- RCM is the larger of the two at $6.21B, about 27.5x TPVG ($225.7M).
- RCM has more recent analyst coverage (25 ratings vs 19 for TPVG).
- Company
- R1 RCM Inc.
- TriplePoint Venture Growth BDC Corp.
- Price
- $14.32+0.07%
- $5.59+1.18%
- Market cap
- $6.21B
- $225.7M
- 1M return
- -
- +2.19%
- 1Y return
- -
- -19.03%
- Industry
- Other Consumer Services
- Other Consumer Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2014
- News (4w)
- 0
- 0
- Recent ratings
- 25
- 19
R1 RCM Inc.
R1 RCM Inc. provides revenue cycle management (RCM) for healthcare providers in the United States. The company offers end-to-end RCM services to manage their revenue cycle operations that encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, bill preparation, and collections from patients and payers. It also provides modular services comprising physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, including charge capture, charge description master maintenance, and pricing services; coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services. In addition, the company offers software-as-a-service based scheduling and patient access solutions. It serves healthcare providers, including health systems, hospitals, and physician groups. The company was formerly known as Accretive Health, Inc. and changed its name to R1 RCM Inc. in January 2017. R1 RCM Inc. was incorporated in 2003 and is headquartered in Chicago, Illinois.
TriplePoint Venture Growth BDC Corp.
TriplePoint Venture Growth BDC Corp is a business development company specializing investments in growth stage. It also provides debt financing to venture growth space companies which includes growth capital loans, equipment financings, revolving loans, and direct equity investments. The fund seeks to invest in e-commerce, entertainment, technology and life sciences sector. Within technology the areas of focus include: Security, wireless communication equipments, network system and software, business applications software, conferencing equipments/services .big data, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, software, software as a service, and other technology related subsectors and within life sciences the areas of focus include: biotechnology, bio fuels/bio mass, diagnostic testing and bioinformatics, drug delivery, drug discovery, healthcare information systems, healthcare services, medical, surgical and therapeutic devices, pharmaceuticals and other life science related subsectors. Within growth capital loans it invests between $5 million and $50 million, for equipment financings it invests between $5 million and $25 million, for revolving loans it invests between $1 million and $25 million, and for direct equity investments it may invest between $0.1 million and $5 million (generally not exceeding 5% of the company's total equity). The debt financing products are typically structured as lines of credit and it invests through warrants and secured loans. It does not take board seat in the company.
Latest RCM
- Amendment: SEC Form SC 13D/A filed by R1 RCM Inc.
- Director New Mountain Capital, L.L.C. disposed of $1,944,593,908 worth of shares (135,985,588 units at $14.30) (SEC Form 4)
- Director Dill David M returned $708,165 worth of shares to the company (49,522 units at $14.30), closing all direct ownership in the company (SEC Form 4)
- Director Henneman John B Iii returned $1,255,040 worth of shares to the company (87,765 units at $14.30), closing all direct ownership in the company (SEC Form 4)
- SEC Form 4 filed by Director Ashdown Clay
- SEC Form 4 filed by Director Wexler Erik G.
- SEC Form 4 filed by Director Nakis Dominic
- Director Bundy Scanlan Agnes returned $472,100 worth of shares to the company (33,014 units at $14.30), closing all direct ownership in the company (SEC Form 4)
- Director Flanagan Joseph Gerard was granted 98,238 shares and returned $49,840,920 worth of shares to the company (3,485,379 units at $14.30), closing all direct ownership in the company (SEC Form 4)
- President Sparby John M. was granted 332,323 shares and returned $9,154,731 worth of shares to the company (640,191 units at $14.30), closing all direct ownership in the company (SEC Form 4)
Latest TPVG
- SEC Form 10-Q filed by TriplePoint Venture Growth BDC Corp.
- TriplePoint Venture Growth BDC Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- TriplePoint Venture Growth BDC Corp. Announces First Quarter 2026 Financial Results
- TriplePoint Venture Growth BDC Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- TriplePoint Venture Growth BDC Corp. to Announce 2026 First Quarter Financial Results on Wednesday, May 6, 2026
- TriplePoint Venture Growth BDC Corp. Investment Grade Rating and Stable Outlook Confirmed by Morningstar DBRS
- SEC Form 40-17G filed by TriplePoint Venture Growth BDC Corp.
- SEC Form DEFA14A filed by TriplePoint Venture Growth BDC Corp.
- SEC Form DEF 14A filed by TriplePoint Venture Growth BDC Corp.
- SEC Form 10-K filed by TriplePoint Venture Growth BDC Corp.